Long-term abatacept treatment for 48 weeks in patients with primary Sjögren's syndrome: The open-label extension phase of the ASAP-III trial
Titel:
Long-term abatacept treatment for 48 weeks in patients with primary Sjögren's syndrome: The open-label extension phase of the ASAP-III trial
Auteur:
de Wolff, Liseth van Nimwegen, Jolien F. Mossel, Esther van Zuiden, Greetje S. Stel, Alja J. Majoor, Kalle I. Olie, Lisette Los, Leonoor I. Vissink, Arjan Spijkervet, Fred K.L. Verstappen, Gwenny M.P.J. Kroese, Frans G.M. Arends, Suzanne Bootsma, Hendrika